Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include Tiara for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. As of April 11, 2023, Neovasc Inc. operates as a subsidiary of Shockwave Medical, Inc.
Date |
For |
Estimate |
Reported |
Surprise |
surprise % |
2023-05-11 |
2023-03 |
0 |
N/A |
N/A |
N/A |
2023-03-31 |
2022-12 |
-1.93 |
N/A |
N/A |
N/A |
2022-11-10 |
2022-09 |
-2.82 |
N/A |
N/A |
N/A |
2022-08-11 |
2022-06 |
-1.25 |
N/A |
N/A |
N/A |
2022-05-12 |
2022-03 |
-1.25 |
N/A |
N/A |
N/A |
2022-03-10 |
2021-12 |
-2.5 |
N/A |
N/A |
N/A |
Date |
Firm |
Action |
From |
To |
2020-11-06 |
SVB Leerink |
Upgrade |
|
Outperform |
2020-11-25 |
H.C. Wainwright |
Upgrade |
|
Buy |
2020-11-25 |
Canaccord Genuity |
Upgrade |
|
Buy |
2020-11-25 |
H.C. Wainwright |
Upgrade |
|
Buy |
2020-11-25 |
Leerink Swann |
Upgrade |
Outperform |
Outperform |
2020-11-25 |
Canaccord Genuity |
Upgrade |
Buy |
Buy |
Date |
Name |
Relation |
Quantity |
Description |
2022-08-17 |
Becker (Lisa Ann McFadde) |
Senior Officer of Issuer |
2.45K |
Exercise of rights |
2022-06-21 |
Clark, Christopher John |
Senior Officer of Issuer |
49.10K |
Exercise of rights |
2022-06-21 |
Colen (Fredericus A) |
Senior Officer of Issuer |
224.15K |
Exercise of rights |
2022-08-17 |
Gallagher (Sarah Marie Hodgson) |
Senior Officer of Issuer |
1.46K |
Exercise of rights |
2022-11-17 |
Geyer (Paul) |
10% Security Holder of Issuer |
18.34K |
Acquisition or disposition in the public market |
2022-08-18 |
Janzen (Doug) |
Director of Issuer |
38.78K |
Acquisition or disposition in the public market |
Institution Ownership
...
Report Date |
Organization |
Position |
Value |
Percentage |
2022-12-30 |
Natixis |
49.78K |
1.49M |
1.84% |
2022-12-30 |
U.S. Capital Wealth Advisors, LLC |
18.78K |
563.96K |
0.69% |
2022-12-30 |
Magnetar Financial LLC |
15.80K |
474.59K |
0.58% |
2022-12-30 |
Choreo, LLC |
12.44K |
373.57K |
0.46% |
2022-12-30 |
Morgan Stanley |
3.64K |
109.16K |
0.13% |
2022-12-30 |
Bank of America Corporation |
2.70K |
81.11K |
0.10% |
Report Date |
Organization |
Position |
Value |
Percentage |
2022-11-29 |
Fidelity NASDAQ Composite Index Fund |
854.00 |
25.65K |
0.03% |
Split |
Date |
1 : 25 |
2022-04-29 |
1 : 10 |
2019-07-02 |
1 : 100 |
2018-09-21 |